Spectroscopic studies of interactions of chondroitin sulfates with cisplatin

被引:7
作者
Zhang, Jing-Shi [1 ]
Anraku, Makoto [1 ,3 ]
Kadowaki, Daisuke [1 ]
Imai, Teruko [1 ]
Suenaga, Ayaka [1 ]
Odani, Akira [4 ]
Otagiri, Masaki [1 ,2 ]
机构
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan
[2] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600082, Japan
[3] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Fukuyama, Hiroshima 7290292, Japan
[4] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan
关键词
Cisplatin; Chondroitin sulfate; Interaction; Capillary electrophoresis; Spectroscopy; NMR; TARGETED DRUG-DELIVERY; HYDROLYSIS PRODUCTS; RANDOMIZED-TRIAL; AQUEOUS-SOLUTION; NEPHROTOXICITY; KINETICS; ANATION; COMPLEX; CIS-DIAMMINEDICHLOROPLATINUM(II); CIS-DICHLORODIAMMINEPLATINUM(II);
D O I
10.1016/j.carres.2011.01.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Complexation of cisplatin (CDDP) and chondroitin sulfate A (CSA) or C (CSC) has been reported to reduce the nephrotoxicity of CDDP. However the mechanism of interaction between CDDP and CSA or CSC was not known. In this study, spectroscopic analyses including NMR were carried out to examine the complexation interactions of CSA and CSC with CDDP. The time-dependent changes in the UV spectra indicate that CSA and CSC effectively complexes with CDDP in aqueous solution and that the reaction occurs subsequent to the hydrolysis of CDDP. The time-dependent change results measured by capillary electrophoresis showed that complexation of chondroitin sulfate (CS) followed first-order reaction kinetics and that the rate of CDDP hydrolysis in the complexation for both CSA and CSC was the same. These results suggested that the mechanism of complexation was a two-step process with monoaqua formation proved to be the first step, which was also the reaction rate controlling step. Moreover. NMR data suggested that the carboxylic and sulfate groups of CS played an important role in its interaction with CDDP. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:631 / 637
页数:7
相关论文
共 26 条
[1]   Chondroitin-4-sulfate protects high-density lipoprotein against copper-dependent oxidation [J].
Albertini, R ;
De Luca, G ;
Passi, A ;
Moratti, R ;
Abuja, PM .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1999, 365 (01) :143-149
[2]   Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: A review of some recent research [J].
Ali, Badreldin H. ;
Al Moundhri, Mansour S. .
FOOD AND CHEMICAL TOXICOLOGY, 2006, 44 (08) :1173-1183
[3]   Pharmacokinetics of cisplatin and its monohydrated complex in humans [J].
Andersson, A ;
Fagerberg, J ;
Lewensohn, R ;
Ehrsson, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (08) :824-827
[4]   SUBCELLULAR-LOCALIZATION OF CIS-DICHLORODIAMMINEPLATINUM(II) IN RAT-KIDNEY AND LIVER [J].
CHOIE, DD ;
DELCAMPO, AA ;
GUARINO, AM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1980, 55 (02) :245-252
[5]   Cumulative toxicities from cisplatin therapy and current cytoprotective measures [J].
Cvitkovic, E .
CANCER TREATMENT REVIEWS, 1998, 24 (04) :265-281
[6]   Reactions of cisplatin hydrolytes with methionine, cysteine, and plasma ultrafiltrate studied by a combination of HPLC and NMR techniques [J].
El-Khateeb, M ;
Appleton, TG ;
Gahan, LR ;
Charles, BG ;
Berners-Price, SJ ;
Bolton, AM .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1999, 77 (1-2) :13-21
[7]   STABILITY OF CISPLATIN IN AQUEOUS-SOLUTION [J].
GREENE, RF ;
CHATTERJI, DC ;
HIRANAKA, PK ;
GALLELLI, JF .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1979, 36 (01) :38-43
[8]  
Hausheer FH, 1998, SEMIN ONCOL, V25, P584
[9]   Exploiting the enhanced permeability and retention effect for tumor targeting [J].
Iyer, Arun K. ;
Khaled, Greish ;
Fang, Jun ;
Maeda, Hiroshi .
DRUG DISCOVERY TODAY, 2006, 11 (17-18) :812-818
[10]  
Kelly G S, 1998, Altern Med Rev, V3, P27